IBio Inc. said June 8 that it it fell out of compliance with NYSE American LLC listing requirements.
The New York biotechnology company received the notice because its stockholders' equity was below the exchange's $6 million minimum requirement, and it booked net losses in its five most recent fiscal years.
IBio has until July 6 to submit a plan showing how it intends to return to compliance by Dec. 6, 2019.
